Drugs / MNC
last change Dec 2019 re-read 2 minutes ago

MNC

Developed for
spastic cerebral palsy
Investigated by
Hormozgan University of Medical Sciences · Tehran University of Medical Sciences

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03795974 Jul 2017 → Oct 2019 spastic cerebral palsy Tehran University of Medical Sciences Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MNC ClinicalTrials.gov intervention name — accepted as the source's own label NCT03795974